How to buy OPKO Health shares

OPKO Health, Inc is a diagnostics & research business with stocks listed in the US. OPKO Health shares (OPK) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was US$3.61 – a decrease of 5.5% over the previous week. Here's how to invest if you're based in Australia.

How to buy shares in OPKO Health

1. Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
3. Search for OPKO Health. Find the share by name or ticker symbol: OPK. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until OPKO Health reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of US$3.61, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of OPKO Health, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of OPKO Health. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

OPKO Health share price

Use our graph to track the performance of OPK stocks over time.

OPKO Health shares at a glance

• Key figures

Information last updated 2021-06-17.

52-week range	US$2.38 - US$6.47
50-day moving average	US$3.7569
200-day moving average	US$4.396
Target price	US$8.25
PE ratio	20.3175
Dividend yield	N/A (0%)
Earnings per share (TTM)	US$0.189

Compare share trading platforms to buy stock

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.

Is it a good time to buy OPKO Health stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of OPKO Health, Inc by TradingView

OPKO Health price performance over time

Historical closes compared with the last close of $3.61

1 week (2021-06-15)	-2.17%
1 month (2021-05-21)	-1.10%
3 months (2021-03-22)	-26.92%
6 months (2020-12-22)	-20.83%

1 year (2020-06-22)	37.26%
2 years (2019-06-21)	79.60%
3 years (2018-06-22)	-21.01%
5 years (2016-06-22)	-61.43%

Is OPKO Health under- or over-valued?

Valuing OPKO Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of OPKO Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

OPKO Health's P/E ratio

OPKO Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 20x. In other words, OPKO Health shares trade at around 20x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

OPKO Health's EBITDA

OPKO Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$216.1 million.

The EBITDA is a measure of a OPKO Health's overall financial performance and is widely used to measure a its profitability.

OPKO Health financials

Revenue TTM	US$1.8 billion
Operating margin TTM	7.51%
Gross profit TTM	US$541 million
Return on assets TTM	3.49%
Return on equity TTM	7.45%
Profit margin	6.83%
Book value	2.532
Market capitalisation	US$2.6 billion

TTM: trailing 12 months

Shorting OPKO Health shares

There are currently 58.0 million OPKO Health shares held short by investors – that's known as OPKO Health's "short interest". This figure is 27.2% down from 79.7 million last month.

There are a few different ways that this level of interest in shorting OPKO Health shares can be evaluated.

OPKO Health's "short interest ratio" (SIR)

OPKO Health's "short interest ratio" (SIR) is the quantity of OPKO Health shares currently shorted divided by the average quantity of OPKO Health shares traded daily (recently around 4.7 million). OPKO Health's SIR currently stands at 12.38. In other words for every 100,000 OPKO Health shares traded daily on the market, roughly 12380 shares are currently held short.

However OPKO Health's short interest can also be evaluated against the total number of OPKO Health shares, or, against the total number of tradable OPKO Health shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case OPKO Health's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 OPKO Health shares in existence, roughly 80 shares are currently held short) or 0.1495% of the tradable shares (for every 100,000 tradable OPKO Health shares, roughly 150 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against OPKO Health.

Find out more about how you can short OPKO Health stock.

OPKO Health share dividends

We're not expecting OPKO Health to pay a dividend over the next 12 months.

OPKO Health share price volatility

Over the last 12 months, OPKO Health's shares have ranged in value from as little as US$2.38 up to US$6.47. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while OPKO Health's is 1.7777. This would suggest that OPKO Health's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

OPKO Health overview

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers and governmental units, as well as 4Kscore prostate cancer testing services. The company's Pharmaceutical segment offers Rayaldee for treatment for secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and associated obesity that is in Phase IIb trials; and hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc. This segment develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins. It also specialty active pharmaceutical ingredients; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. In addition, the company operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. OPKO Health, Inc. was incorporated in 1991 and is headquartered in Miami, Florida.

Frequently asked questions

• What percentage of OPKO Health is owned by insiders or institutions?

  Currently 40.317% of OPKO Health shares are held by insiders and 29.539% by institutions.

• When does the fiscal year end for OPKO Health?

  OPKO Health's fiscal year ends in December.

• Where is OPKO Health based?

  OPKO Health's address is: 4400 Biscayne Boulevard, Miami, FL, United States, 33137

• What is OPKO Health's ISIN number?

  OPKO Health's international securities identification number is: US68375N1037

• What is OPKO Health's CUSIP number?

  OPKO Health's Committee on Uniform Securities Identification Procedures number is: 23282G105